PubRank

Robert D Goldin

Author PubWeight™ 45.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Histological outcome during long-term lamivudine therapy. Gastroenterology 2003 3.88
2 Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006 3.46
3 Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012 2.91
4 Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003 2.43
5 Quantifying hepatic steatosis - more than meets the eye. Histopathology 2012 1.76
6 Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatol 2005 1.58
7 Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann Surg 2014 1.58
8 Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin Sci (Lond) 2009 1.47
9 Jaundiced after a party. BMJ 2011 1.38
10 The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003 1.34
11 Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci U S A 2012 1.31
12 Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J Hepatol 2010 1.23
13 The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 2012 1.21
14 Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006 1.21
15 Epithelioid angiomyolipoma of the liver: case report and review of the literature. APMIS 2004 1.11
16 LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice. Biochem J 2011 1.08
17 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication. J Proteome Res 2013 1.08
18 Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut 2010 1.05
19 Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer. Proc Natl Acad Sci U S A 2014 1.02
20 Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol 2005 1.01
21 Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver. J Proteome Res 2012 1.00
22 Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006 0.96
23 ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Proc Natl Acad Sci U S A 2013 0.94
24 Morphological analysis of optical coherence tomography images for automated classification of gastrointestinal tissues. Biomed Opt Express 2011 0.91
25 Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study. J Hepatol 2009 0.86
26 Stat2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsis. Proc Natl Acad Sci U S A 2013 0.86
27 Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'. AIDS 2007 0.82
28 In vivo thermography during small bowel fusion using radiofrequency energy. Surg Endosc 2010 0.82
29 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. AJR Am J Roentgenol 2007 0.82
30 Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 2012 0.82
31 Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? Hepatology 2010 0.81
32 Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis? BMC Res Notes 2008 0.80
33 Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C. Hepatol Res 2012 0.80
34 Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease. Lasers Surg Med 2011 0.77
35 Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report. AIDS 2015 0.75
36 Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature. BMC Gastroenterol 2014 0.75
37 Lipid profiling of pre-treatment liver biopsy tissue predicts sustained virological response in patients with chronic hepatitis C. Hepatol Res 2012 0.75
38 Radiofrequency-induced small bowel thermofusion: an ex vivo study of intestinal seal adequacy using mechanical and imaging modalities. Surg Endosc 2013 0.75
39 Physiological hepatic nuclear vacuolation--how long does it persist? Histopathology 2010 0.75